NCT02391506 (GRIP) is a NA clinical trial of Cartiva in Osteoarthritis, sponsored by Cartiva, Inc..

Who is sponsoring NCT02391506?

NCT02391506 is sponsored by Cartiva, Inc..

What drugs are being tested in NCT02391506?

Interventions in NCT02391506: Cartiva.

What condition does NCT02391506 study?

NCT02391506 studies Osteoarthritis.

Is NCT02391506 still recruiting?

NCT02391506 is currently completed. Last updated 22 March 2019.

Last reviewed 2019-03-22 · How we verify

NCT02391506: GRIP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis

Completed NA Last updated 22 March 2019

What this trial tests

NA trial testing Cartiva in Osteoarthritis in 50 participants. Completed in 5 March 2019.

Timeline

29 July 2015

Primary endpoint
5 March 2019

5 March 2019

Quick facts

Lead sponsor	Cartiva, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	29 July 2015
Primary completion	5 March 2019
Estimated completion	5 March 2019
Sites	9 locations across United Kingdom, Canada

Drugs / interventions tested

Cartiva

Conditions studied

Osteoarthritis — all drugs for Osteoarthritis →

Sponsor

Cartiva, Inc.

Who can join

18 and older, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate whether Cartiva is an effective treatment for individuals with osteoarthritis of the CMC joint in the hand.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

NCT07404891 — Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis · NA · recruiting
NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02391506 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cartiva, Inc.
Last refreshed: 22 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02391506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing